![](/img/cover-not-exists.png)
Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)
G. G. Kimmick, C. Cirrincione, D. B. Duggan, K. Bhalla, N. Robert, D. Berry, L. Norton, S. Lemke, I. C. Henderson, C. Hudis, E. Winer, On Behalf of the Cancer and Leukemia Group BVolume:
113
Language:
english
Pages:
12
DOI:
10.1007/s10549-008-9943-2
Date:
February, 2009
File:
PDF, 325 KB
english, 2009